BARMR1-mediated sorafenib resistance is derived through stem-like property acquisition by activating integrin-FAK signaling pathways

Signal Transduct Target Ther. 2020 Jun 12;5(1):97. doi: 10.1038/s41392-020-0189-8.

Xing Rong Guo^#^{1

2}, Meng Ye Shan^#^{3

4}, Yu Huang^{3

5}, Zong Li Zhang^{3

5}, Yue Yuan³, Long Jun Dai^{6

7}, Jue Wang⁵, Xue Peng Zhou⁸, Fu Yun Ji⁵, Jun Ming Tang⁵, Zhong Ji Meng^{9

10}, Xu Zhi Ruan¹¹

¹ Hubei Key Laboratory of Embryonic Stem Cell Research, Taihe Hospital, Hubei University of Medicine, 442000, Shiyan, Hubei, China. gxrdl@126.com.
² College of Basic Medicine, Hubei University of Medicine, 442000, Shiyan, Hubei, China. gxrdl@126.com.
³ Hubei Key Laboratory of Embryonic Stem Cell Research, Taihe Hospital, Hubei University of Medicine, 442000, Shiyan, Hubei, China.
⁴ Jiangsu Hengrui Medicine Co. Ltd, Lianyungang, China.
⁵ College of Basic Medicine, Hubei University of Medicine, 442000, Shiyan, Hubei, China.
⁶ Department of Neurosurgery, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
⁷ Department of Surgery, University of British Columbia, Vancouver, BC, Canada.
⁸ Hepatobiliary and Pancreatic Surgery Diagnosis and Treatment Center, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
⁹ Institute of Biomedical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
¹⁰ Department of Infectious Diseases, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
¹¹ College of Basic Medicine, Hubei University of Medicine, 442000, Shiyan, Hubei, China. ruanxuzhi@163.com.

^# Contributed equally.

No abstract available

Publication types